Page 333 - Read Online

Monks et al. J Cancer Metastasis Treat 2019;5:24 I http://dx.doi.org/10.20517/2394-4722.2018.79 Page 19 of 23

Gastroenterol 2014;49:1342-51.
63. Shin E, Yu YD, Kim DS, Won NH. Adiponectin receptor expression predicts favorable prognosis in cases of hepatocellular carcinoma.
Pathol Oncol Res 2014;20:667-75.
64. Petridou ET, Mitsiades N, Gialamas S, Angelopoulos M, Skalkidou A, et al. Circulating adiponectin levels and expression of adiponectin
receptors in relation to lung cancer: two case-control studies. Oncology 2007;73:261-9.
65. Katira A, Tan PH. Evolving role of adiponectin in cancer-controversies and update. Cancer Biol Med 2016;13:101-19.
66. Erichsen HC, Chanock SJ. SNPs in cancer research and treatment. Br J Cancer 2004;90:747-51.
67. Erarslan E, Turkay C, Koktener A, Koca C, Uz B, et al. Association of visceral fat accumulation and adiponectin levels with colorectal
neoplasia. Dig Dis Sci 2009;54:862-8.
68. Kemik O, Sumer A, Kemik A, Hasirci I, Purisa S, et al. The relationship among acute-phase response proteins, cytokines and hormones in
cachectic patients with colon cancer. World J Surg Oncol 2010;8:85.
69. Nakajima TE, Yamada Y, Hamano T, Furuta K, Matsuda T, et al. Adipocytokines as new promising markers of colorectal tumors:
adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci 2010;101:1286-91.
70. Aleksandrova K, Boeing H, Jenab M, Bueno-de-Mesquita HB, Jansen E, et al. Total and high-molecular weight adiponectin and risk of
colorectal cancer: the European prospective investigation into cancer and nutrition study. Carcinogenesis 2012;33:1211-8.
71. Lukanova A, Söderberg S, Kaaks R, Jellum E, Stattin P. Serum adiponectin is not associated with risk of colorectal cancer. Cancer
Epidemiol Biomarkers Prev 2006;15:401-2.
72. Stocks T, Lukanova A, Johansson M, Rinaldi S, Palmqvist R, et al. Components of the metabolic syndrome and colorectal cancer risk; a
prospective study. Int J Obes 2008;32:304-14.
73. Nakajima TE, Yamada Y, Hamano T, Furuta K, Gotoda T, et al. Adipocytokine levels in gastric cancer patients: resistin and visfatin as
biomarkers of gastric cancer. J Gastroenterol 2009;44:685-90.
74. Ishikawa M, Kitayama J, Kazama S, Hiramatsu T, Hatano K, et al. Plasma adiponectin and gastric cancer. Clin Cancer Res 2005;11:466-72.
75. Seker M, Bilici A, Sonmez B, Ustaalioğlu BBO, Gumus M, et al. The association of serum adiponectin levels with histopathological
variables in gastric cancer patients. Med Oncol 2010;27:1319-23.
76. Yildirim A, Bilici M, Cayir K, Yanmaz V, Yildirim S, et al. Serum adiponectin levels in patients with esophageal cancer. Jpn J Clin Oncol
2008;39:92-6.
77. Duggan C, Onstad L, Hardikar S, Blount PL, Reid BJ, et al. Association between markers of obesity and progression from Barrett’s
esophagus to esophageal adenocarcinoma. Clin Gastroenterol Hepatol 2013;11:934-43.
78. Nakajima TE, Yamada Y, Hamano T, Furuta K, Oda I, et al. Adipocytokines and squamous cell carcinoma of the esophagus. J Cancer Res
Clin Oncol 2010;136:261-6.
79. Diao Y, Li H, Li H, Zhou Y, Ma Q, et al. Association of serum levels of lipid and its novel constituents with the different stages of
esophageal carcinoma. Lipids Health Dis 2009;8:48.
80. Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, et al. Adiponectin and Breast Cancer Risk. J Clin Endocrinol Metab
2004;89:1102-7.
81. Duggan C, Irwin ML, Xiao L, Henderson KD, Smith AW, et al. Associations of insulin resistance and adiponectin with mortality in women
with breast cancer. J Clin Oncol 2011;29:32-9.
82. Macis D, Gandini S, Guerrieri-Gonzaga A, Johansson H, Magni P, et al. Prognostic effect of circulating adiponectin in a randomized 2 × 2
trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer. J Clin Oncol 2012;30:151-7.
83. Kang JH, Yu BY, Youn DS. Relationship of serum adiponectin and resistin levels with breast cancer risk. J Korean Med Sci 2007;22:117.
84. Hou WK, Xu YX, Yu T, Zhang L, Zhang WW, et al. Adipocytokines and breast cancer risk. Chin Med J (Engl) 2007;120:1592-6.
85. Tworoger SS, Eliassen AH, Kelesidis T, Colditz GA, Willett WC, et al. Plasma adiponectin concentrations and risk of incident breast cancer.
J Clin Endocrinol Metab 2007;92:1510-6.
86. Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, et al. Plasma adiponectin levels and endometrial cancer risk in pre- and
postmenopausal women. J Clin Endocrinol Metab 2007;92:255-63.
87. Ma Y, Liu Z, Zhang Y, Lu B. Serum leptin, adiponectin and endometrial cancer risk in Chinese women. J Gynecol Oncol 2013;24:336-41.
88. Bohlouli S, Khazaei M, Teshfam M, Hassanpour H. Adiponectin effect on the viability of human endometrial stromal cells and mRNA
expression of adiponectin receptors. Int J Fertil Steril 2013;7:43-8.
89. Bao Y, Giovannucci EL, Kraft P, Stampfer MJ, Ogino S, et al. A prospective study of plasma adiponectin and pancreatic cancer risk in five
US cohorts. J Natl Cancer Inst 2013;105:95-103.
90. Chang MC, Chang YT, Su TC, Yang WS, Chen CL, et al. Adiponectin as a potential differential marker to distinguish pancreatic cancer and
chronic pancreatitis. Pancreas 2007;35:16-21.
91. Krechler T, Zeman M, Vecka M, Macasek J, Jachymova M, et al. Leptin and adiponectin in pancreatic cancer: connection with diabetes
mellitus. Neoplasma 2011;58:58-64.
92. Kotani K, Wakai K, Shibata A, Fujita Y, Ogimoto I, et al. Serum adiponectin multimer complexes and liver cancer risk in a large cohort
study in Japan. Asian Pac J Cancer Prev 2009;10 Suppl:87-90.
93. Sumie S, Kawaguchi T, Kuromatsu R, Takata A, Nakano M, et al. Total and high molecular weight adiponectin and hepatocellular
carcinoma with HCV infection. PLoS One 2011;6:e26840.
94. Li H, Stampfer MJ, Mucci L, Rifai N, Qiu W, et al. A 25-year prospective study of plasma adiponectin and leptin concentrations and
prostate cancer risk and survival. Clin Chem 2010;56:34-43.
95. Michalakis K, Williams CJ, Mitsiades N, Blakeman J, Balafouta-Tselenis S, et al. Serum adiponectin concentrations and tissue
expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study. Cancer Epidemiol Biomarkers Prev
2007;16:308-13.
96. Arisan ED, Arisan S, Atis G, Palavan-Unsal N, Ergenekon E. Serum adipocytokine levels in prostate cancer patients. Urol Int